Prospective Evaluation of Immunity After COVID Vaccines Study

Addressing vaccine immunity and protection in population groups that have an increased risk of developing severe illness from COVID-19, such as those aged 50 years and above, is paramount to inform public health policies on the deployment of booster vaccines. This study will establish the vaccine-elicited humoral immunity and immune protection of the different COVID-19 vaccines by measuring the concentration of antibodies that are able to recognize SARS-CoV-2 virus in the blood. Findings obtained from this study will provide scientific evidence on vaccine effectiveness in those at higher risk of developing severe disease and will help guide public health policy on vaccination schedules.

BC CDC Presenters

10/21/2021 5:20:00 PM